Cystic Adnexal Mass Differential Diagnosis: A Comprehensive Guide for Auto Repair Experts

Introduction

Ovarian cysts, fluid-filled sacs that can be simple or complex, are frequently encountered in women, often discovered incidentally during routine physical examinations or imaging procedures. While many are benign, ovarian cysts can lead to significant complications such as rupture, hemorrhage, and ovarian torsion, all of which are considered gynecological emergencies. Prompt and accurate diagnosis, therefore, is crucial for effective management and to prevent potentially life-threatening situations. This article provides an in-depth review of the differential diagnosis of cystic adnexal masses, aiming to enhance the understanding of auto repair experts who, while not directly involved in medical diagnosis, may encounter related scenarios in discussions with clients or in broader contexts of health and wellness. Understanding the complexities of conditions like cystic adnexal masses can improve communication and empathy in client interactions.

The adnexa refers to the structures adjacent to the uterus, primarily the ovaries and fallopian tubes. Although fallopian tubes are part of the adnexa, this discussion will concentrate on the ovaries and the various types of cysts that can develop within them. Ovaries are positioned laterally to the uterus, supported by ligaments like the utero-ovarian and infundibulopelvic ligaments. In women of reproductive age, the ovaries undergo monthly cycles, producing follicles, with one dominant follicle maturing and ovulating each cycle. This normal physiological process can sometimes lead to the formation of ovarian cysts. Adnexal masses, including ovarian cysts, are common, affecting a significant proportion of women during their lifetime. While most are benign and functional, understanding the differential diagnosis is key to distinguishing benign conditions from those requiring intervention or further investigation, including potentially malignant lesions. This article will delve into the Cystic Adnexal Mass Differential Diagnosis, providing a structured approach to understanding this complex clinical picture.

Etiology of Cystic Adnexal Masses

The causes of cystic adnexal masses are diverse, ranging from normal physiological occurrences to malignant neoplasms. Understanding the etiology is fundamental to constructing an accurate differential diagnosis. Ovarian cysts are most prevalent during reproductive years due to hormonal activity but can occur across all age groups. Simple cysts are generally more common and often benign, while complex, solid, or mixed lesions raise greater concern for malignancy. Age is a critical factor, with postmenopausal women having a higher risk of malignancy associated with any adnexal cyst.

Risk factors for ovarian cyst formation are varied and include:

Hormonal Imbalances: Fluctuations and imbalances in hormones, particularly during the menstrual cycle, pregnancy, or conditions like polycystic ovary syndrome (PCOS), can contribute to cyst development.
Ovulation Induction: Fertility treatments that stimulate ovulation can increase the risk of functional cysts.
Hypothyroidism: While less common, hypothyroidism has been associated with the development of ovarian cysts in some cases.
Tamoxifen Therapy: This medication, used in breast cancer treatment, has been linked to ovarian cyst formation in some patients.
Smoking and Marijuana Use: Some studies suggest a correlation between smoking and marijuana use with an increased risk of functional ovarian cysts, particularly in relation to body mass index.
Oral Contraceptives: While often used to manage cysts, the relationship between oral contraceptives and cyst risk is complex and may vary depending on the type of cyst.

Epidemiology of Ovarian Cysts

The precise prevalence of ovarian cysts is difficult to determine because many women are asymptomatic and undiagnosed. Prevalence rates vary depending on the population studied. It is estimated that approximately 4% of women will be hospitalized for ovarian cysts by the age of 65. Studies have shown that in asymptomatic women of reproductive age, the prevalence of adnexal lesions can be around 7-8%. In postmenopausal women, simple unilocular cysts have been found in around 2.5% of the population. Large-scale surveys using transvaginal ultrasound have reported even higher rates of adnexal cysts, with a significant percentage resolving spontaneously on follow-up.

Mature cystic teratomas (dermoids) represent a notable proportion of ovarian neoplasms, exceeding 10% in some studies. Ovarian cysts are also the most common type of tumor in infants and fetuses, with prevalence rates exceeding 30% in some populations. While most of these are benign, the significant incidence underscores the importance of understanding and appropriately managing ovarian cysts across all age groups. In contrast to benign cysts, ovarian carcinomas, while less frequent, are a serious concern. In the United States, tens of thousands of women are diagnosed with ovarian cancer annually, resulting in a significant number of deaths. This highlights the critical need for accurate differential diagnosis to distinguish benign from malignant cystic adnexal masses.

Pathophysiology of Ovarian Cysts

Understanding the pathophysiology helps categorize cysts and informs the differential diagnosis. The normal menstrual cycle involves follicle development under the influence of follicle-stimulating hormone (FSH), leading to ovulation triggered by a luteinizing hormone (LH) surge. After ovulation, the corpus luteum forms and produces progesterone. Disruptions in this cycle can lead to cyst formation.

Functional Cysts

Functional cysts arise from normal ovarian function and are typically benign and transient.

Follicular and Corpus Luteal Cysts

These are the most common types of functional cysts. Follicular cysts develop when a follicle fails to rupture and release an egg during ovulation. They are usually thin-walled, unilocular, and filled with fluid. They can result from excessive FSH stimulation or lack of the LH surge. Corpus luteal cysts occur after ovulation when the corpus luteum, instead of dissolving, fills with fluid or blood. They can be simple or complex, sometimes with thick walls or internal debris. Both types can become hemorrhagic cysts if bleeding occurs within them. These functional cysts are often asymptomatic and typically resolve spontaneously within a few menstrual cycles.

Theca Lutein Cysts

Theca lutein cysts are less common and are associated with elevated levels of human chorionic gonadotropin (hCG). They are often seen in pregnancy, gestational trophoblastic disease, multiple gestations, and ovarian hyperstimulation syndrome. These cysts are typically bilateral and multilocular.

Polycystic Ovary Syndrome (PCOS)

PCOS is a hormonal disorder characterized by multiple small follicular cysts in enlarged ovaries, along with other symptoms like hyperandrogenism and irregular periods. In PCOS, the ovaries are enlarged due to hormonal imbalances, leading to the formation of numerous small cysts. PCOS is a significant cause of infertility and is associated with metabolic disorders like diabetes and cardiovascular disease.

Neoplastic Cysts

Neoplastic cysts arise from abnormal cell growth within the ovary and can be benign or malignant.

Benign Neoplastic Cysts

Surface Epithelial Tumors: Serous and mucinous cystadenomas are common benign tumors arising from the ovarian surface epithelium. Serous cystadenomas are typically thin-walled and filled with serous fluid, while mucinous cystadenomas contain thicker, mucinous fluid.
Germ Cell Tumors: Mature cystic teratomas (dermoid cysts) are benign germ cell tumors containing tissues from all three germ layers. They can contain hair, teeth, skin, and other tissues, giving them a complex and varied appearance on imaging. Struma ovarii, a specialized teratoma, is composed mainly of thyroid tissue.
Stromal Tumors: While stromal tumors are more often solid, some can have cystic components. Fibromas and thecomas are examples of benign stromal tumors.

Malignant Neoplastic Cysts

Malignant ovarian cysts can arise from all ovarian subtypes, most frequently from the surface epithelium.

Epithelial Ovarian Cancers: These include serous carcinoma, mucinous carcinoma, endometrioid carcinoma, clear cell carcinoma, and malignant Brenner tumors. Epithelial malignancies are often partially cystic.
Malignant Germ Cell Tumors: These are less common and include immature teratoma, endodermal sinus tumors, embryonal carcinoma, and polyembryoma.

Endometriomas

Endometriomas are cysts that develop due to endometriosis, where endometrial tissue grows outside the uterus, commonly in the ovaries. These cysts are filled with old blood and are often called “chocolate cysts” due to their dark, thick content. Endometriomas typically appear as complex masses on ultrasound with characteristic “ground glass” internal echoes. While the risk of malignant transformation in endometriomas is low, it is slightly increased in women with endometriosis.

History and Physical Examination in Cystic Adnexal Mass Diagnosis

While many ovarian cysts are found incidentally, a thorough medical history and physical examination are crucial. Emphasis should be placed on gynecological history, family history, and current symptoms. Ovarian cysts can be asymptomatic or symptomatic.

Symptoms may include:

Pelvic Pain: Unilateral lower abdominal or pelvic pain or pressure, which can be intermittent or constant, sharp or dull.
Acute Severe Pain: Sudden onset of intense pain, potentially with nausea and vomiting, suggesting cyst rupture or ovarian torsion.
Menstrual Irregularities: Changes in menstrual cycle, including irregular bleeding or abnormal vaginal bleeding.
Bloating and Abdominal Fullness: Some women may experience nonspecific symptoms like bloating or a feeling of fullness in the abdomen.

Physical Examination:

A bimanual pelvic examination can help assess the ovaries for:

Location: Adnexal area.
Size: Estimation of cyst diameter.
Shape: Regular or irregular contour.
Consistency: Cystic, solid, or mixed.
Tenderness: Pain on palpation.
Mobility: Whether the mass is fixed or mobile.

However, pelvic examination alone has limited diagnostic accuracy for ovarian cysts, especially in obese patients or when masses are small. Imaging is essential for definitive diagnosis.

Evaluation of Cystic Adnexal Masses

The evaluation process begins by determining the patient’s menopausal status. In premenopausal women, a pregnancy test (serum beta hCG or urine) is the first step to rule out ectopic pregnancy or pregnancy-related cysts. Once pregnancy is excluded, imaging is necessary.

Initial Evaluation may include:

Pregnancy Test: Essential to rule out pregnancy.
Complete Blood Count (CBC): To assess for anemia if hemorrhage is suspected.
Urinalysis: To rule out urinary tract infection or kidney stones, which can mimic adnexal pain.
Pelvic Inflammatory Disease (PID) Screening: Endocervical swabs to test for sexually transmitted infections if PID is considered in the differential diagnosis.
Cancer Antigen 125 (CA-125): This tumor marker is often elevated in epithelial ovarian cancer, particularly in postmenopausal women. While not specific for malignancy (can be elevated in benign conditions like endometriosis and PID), CA-125, combined with ultrasound findings, aids in risk assessment.

Imaging Modalities:

Transvaginal Ultrasonography (TVUS): The primary imaging modality for evaluating adnexal masses due to its high resolution and ability to characterize cysts as simple or complex, unilocular or multilocular, and identify solid components, septations, papillary excrescences, and assess blood flow with color Doppler. Ultrasound features suggestive of benign cysts include thin, smooth walls, absence of septations or solid components, and no internal flow on Doppler.
Abdominal Ultrasonography: Can be used adjunctively, particularly if pelvic anatomy is distorted or for larger masses extending into the abdomen.
Magnetic Resonance Imaging (MRI) and Computed Tomography (CT): Generally not first-line for initial evaluation but may be used for further characterization of complex masses or when malignancy is suspected based on ultrasound findings. MRI is excellent for tissue characterization, while CT can be useful for staging if cancer is suspected.

Assessment for Ovarian Torsion:

Ovarian torsion, a gynecological emergency, must be considered in patients presenting with acute pelvic pain and an adnexal mass. While Doppler ultrasound is used to assess blood flow, normal Doppler flow does not exclude torsion due to intermittent torsion or dual blood supply to the ovary. Clinical suspicion remains paramount.

Features Suggesting Malignancy on Ultrasound:

Cyst size > 10 cm
Complex multilocular mass
Papillary excrescences or solid components
Irregular walls
Thick septations (>3mm)
Ascites (free fluid in the pelvis)
Increased vascularity on color Doppler

When these features are present, gynecologic oncology consultation should be considered.

Differential Diagnosis of Cystic Adnexal Masses

The differential diagnosis of cystic adnexal masses is broad, encompassing both gynecological and non-gynecological conditions. A systematic approach is essential for accurate diagnosis.

Gynecological Differential Diagnosis

Benign Conditions:

Functional Cysts: Follicular cysts, corpus luteal cysts, hemorrhagic cysts. These are the most common benign cystic adnexal masses, related to the normal menstrual cycle.
Endometrioma: Cysts associated with endometriosis, often with characteristic “ground glass” appearance on ultrasound.
Mature Teratoma (Dermoid Cyst): Benign germ cell tumor, often containing fat, hair, teeth, and other tissues, with variable ultrasound appearance.
Serous Cystadenoma and Mucinous Cystadenoma: Benign epithelial tumors, typically thin-walled (serous) or multilocular with mucinous fluid (mucinous).
Paraovarian Cyst (Paratubal Cyst): Cysts arising from tissues adjacent to the ovary or fallopian tube, separate from the ovary itself.
Hydrosalpinx: Fluid-filled fallopian tube, may appear cystic in the adnexa but is tubular in shape on ultrasound.
Tubo-ovarian Abscess (TOA): Infectious mass involving the ovary and fallopian tube, often complex and inflammatory, associated with pelvic inflammatory disease.
Leiomyoma (Uterine Fibroid): While typically solid, pedunculated or cystic degeneration of a uterine fibroid located in the adnexa can mimic an adnexal cyst.

Malignant Conditions:

Epithelial Ovarian Carcinoma: Serous, mucinous, endometrioid, clear cell carcinomas. These are the most common types of ovarian cancer and can present as complex cystic masses.
Germ Cell Tumors (Malignant): Immature teratoma, dysgerminoma, endodermal sinus tumor, embryonal carcinoma, choriocarcinoma. Less common than epithelial cancers, often occur in younger women.
Sex Cord-Stromal Tumors: Granulosa cell tumor, Sertoli-Leydig cell tumor. Rare ovarian tumors, can sometimes be cystic.
Metastatic Cancer to the Ovary: Cancer from other sites (e.g., colon, breast, stomach) can metastasize to the ovaries, sometimes presenting as cystic masses.

Other Gynecological Conditions:

Pelvic Inflammatory Disease (PID): Inflammation and infection of the pelvic organs can lead to complex adnexal masses, including TOA.
Ectopic Pregnancy: While not strictly an ovarian cyst, ectopic pregnancy (particularly tubal pregnancy) can present as an adnexal mass and must be considered in women of reproductive age with pelvic pain.

Non-Gynecological Differential Diagnosis

Appendicitis: Inflammation of the appendix can cause right lower quadrant pain and may mimic an adnexal mass, particularly if the appendix is pelvic.
Diverticulitis: Inflammation of colonic diverticula, especially sigmoid diverticulitis, can cause left lower quadrant pain and may be confused with adnexal pathology.
Pelvic Kidney: An ectopic kidney located in the pelvis can present as an adnexal mass.
Gastrointestinal Cancer: Colorectal cancer or other gastrointestinal malignancies can sometimes present with pelvic masses that may mimic adnexal cysts.
Urinary Tract Infection (UTI) and Nephrolithiasis (Kidney Stones): While primarily causing urinary symptoms, UTI and kidney stones can present with lower abdominal or pelvic pain, mimicking symptoms of ovarian cysts.
Psoas Abscess: Abscess in the psoas muscle can present with pelvic pain and may be considered in the differential diagnosis, particularly if inflammatory markers are elevated.

Treatment and Management of Cystic Adnexal Masses

Management strategies depend on patient age, menopausal status, cyst size and characteristics, and suspicion of malignancy.

Conservative Management:

Observation: For simple unilocular cysts < 10 cm in premenopausal women, especially if asymptomatic. Serial transvaginal ultrasounds are used to monitor for spontaneous resolution, which is common for functional cysts. Follow-up is typically recommended in 6-12 weeks. If the cyst persists beyond a few menstrual cycles, further evaluation is needed.
Expectant Management of Fetal and Pregnancy-Associated Cysts: Most fetal ovarian cysts and pregnancy-related cysts (corpus luteal and follicular) resolve spontaneously. Conservative management with ultrasound monitoring is usually appropriate.

Surgical Management:

Surgical intervention is indicated in cases of:

Suspected Ovarian Torsion: Emergency surgery (laparoscopy or laparotomy) for detorsion to preserve ovarian function.
Persistent Adnexal Mass: Cysts that do not resolve spontaneously, particularly if symptomatic or complex.
Acute Abdominal Pain: When conservative measures fail to relieve pain, or if rupture or hemorrhage is suspected.
Suspicion of Malignancy: Based on ultrasound features, CA-125 levels, or clinical risk factors.

Surgical Approaches:

Laparoscopy: Minimally invasive surgery, preferred for benign conditions and stable patients. Allows for cystectomy (cyst removal) or oophorectomy (ovary removal). Fertility preservation is prioritized in premenopausal women.
Laparotomy: Open abdominal surgery, may be necessary for large masses, suspected malignancy, or hemodynamically unstable patients (e.g., in cases of significant hemorrhage).

Specific Cyst Types Management:

Endometriomas: Follow-up sonograms every 6-12 weeks initially, then annually until surgical removal if indicated (for pain, infertility, or suspicion of malignancy).
Dermoid Cysts: Yearly ultrasound follow-up until surgical removal is considered (due to risk of torsion, rupture, or rare malignant transformation).

Prognosis of Ovarian Cysts

The prognosis for most ovarian cysts is excellent, as they are often benign, asymptomatic, and resolve spontaneously. Functional cysts have a high rate of spontaneous resolution (70-80%). Benign ovarian cystadenomas generally have a favorable prognosis. Low malignant potential tumors also tend to have a good prognosis with high 5-year survival rates. However, malignant transformation can occur in rare cases of dermoid cysts or endometriomas, and the prognosis for ovarian cancer is generally poorer, especially when diagnosed at advanced stages. Early detection and appropriate management are crucial for improving outcomes in cases of malignant cystic adnexal masses.

Complications of Ovarian Cysts

The main complications requiring emergency attention are:

Ovarian Torsion: Twisting of the ovary, cutting off blood supply, leading to severe pain and potential ovarian necrosis.
Cyst Rupture: Spillage of cyst contents into the pelvis, causing pain, and in some cases, hemorrhage.
Hemorrhage: Bleeding within the cyst or into the peritoneal cavity, potentially leading to hemodynamic instability.

Ovarian torsion is a gynecological emergency requiring prompt diagnosis and surgical intervention to preserve ovarian function. Rupture and hemorrhage are often self-limiting but can sometimes necessitate hospitalization and surgical management if bleeding is significant.

Enhancing Healthcare Team Outcomes

Optimal management of cystic adnexal masses requires a collaborative interprofessional healthcare team, including:

Obstetrician/Gynecologist
Infertility and Reproductive Endocrinologist
Gynecologic Oncologist
General Surgeon
Radiologist
Pathologist

Effective communication and shared decision-making among team members are essential for accurate diagnosis, timely intervention, and improved patient outcomes. Referral to a gynecologic oncologist is recommended for patients with suspected ovarian malignancy based on clinical and imaging findings. Utilizing guidelines for referral ensures that high-risk patients receive specialized care promptly.

Conclusion

Cystic adnexal masses represent a broad spectrum of conditions, ranging from benign functional cysts to malignant neoplasms. Understanding the differential diagnosis is crucial for appropriate evaluation and management. A systematic approach incorporating patient history, physical examination, imaging (primarily transvaginal ultrasound), and relevant laboratory tests is essential. While most ovarian cysts are benign and resolve spontaneously, awareness of potential complications like torsion, rupture, and hemorrhage, as well as the possibility of malignancy, is vital for ensuring timely and effective patient care. For auto repair experts, while the medical details are outside their direct practice, understanding complex diagnostic scenarios like this can enhance their broader awareness of health issues and improve client interactions in a holistic sense.

References

1.Terzic M, Aimagambetova G, Norton M, Della Corte L, Marín-Buck A, Lisón JF, Amer-Cuenca JJ, Zito G, Garzon S, Caruso S, Rapisarda AMC, Cianci A. Scoring systems for the evaluation of adnexal masses nature: current knowledge and clinical applications. J Obstet Gynaecol. 2021 Apr;41(3):340-347.
2.Pakhomov SP, Orlova VS, Verzilina IN, Sukhih NV, Nagorniy AV, Matrosova AV. Risk Factors and Methods for Predicting Ovarian Hyperstimulation Syndrome (OHSS) in the in vitro Fertilization. Arch Razi Inst. 2021 Nov;76(5):1461-1468.
3.Lee S, Kim YH, Kim SC, Joo JK, Seo DS, Kim KH, Lee KS. The effect of tamoxifen therapy on the endometrium and ovarian cyst formation in patients with breast cancer. Obstet Gynecol Sci. 2018 Sep;61(5):615-620.
4.Kelleher CM, Goldstein AM. Adnexal masses in children and adolescents. Clin Obstet Gynecol. 2015 Mar;58(1):76-92.
5.American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology. Practice Bulletin No. 174: Evaluation and Management of Adnexal Masses. Obstet Gynecol. 2016 Nov;128(5):e210-e226.
6.Stany MP, Hamilton CA. Benign disorders of the ovary. Obstet Gynecol Clin North Am. 2008 Jun;35(2):271-84, ix.
7.Tresa A, Rema P, Suchetha S, Dinesh D, Sivaranjith J, Nath AG. Hypothyroidism Presenting as Ovarian Cysts-a Case Series. Indian J Surg Oncol. 2021 Dec;12(Suppl 2):343-347.
8.Heling KS, Chaoui R, Kirchmair F, Stadie S, Bollmann R. Fetal ovarian cysts: prenatal diagnosis, management and postnatal outcome. Ultrasound Obstet Gynecol. 2002 Jul;20(1):47-50.
9.Holt VL, Cushing-Haugen KL, Daling JR. Risk of functional ovarian cyst: effects of smoking and marijuana use according to body mass index. Am J Epidemiol. 2005 Mar 15;161(6):520-5.
10.Holt VL, Cushing-Haugen KL, Daling JR. Oral contraceptives, tubal sterilization, and functional ovarian cyst risk. Obstet Gynecol. 2003 Aug;102(2):252-8.
11.Bottomley C, Bourne T. Diagnosis and management of ovarian cyst accidents. Best Pract Res Clin Obstet Gynaecol. 2009 Oct;23(5):711-24.
12.Borgfeldt C, Andolf E. Transvaginal sonographic ovarian findings in a random sample of women 25-40 years old. Ultrasound Obstet Gynecol. 1999 May;13(5):345-50.
13.Castillo G, Alcázar JL, Jurado M. Natural history of sonographically detected simple unilocular adnexal cysts in asymptomatic postmenopausal women. Gynecol Oncol. 2004 Mar;92(3):965-9.
14.Pavlik EJ, Ueland FR, Miller RW, Ubellacker JM, DeSimone CP, Elder J, Hoff J, Baldwin L, Kryscio RJ, van Nagell JR. Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography. Obstet Gynecol. 2013 Aug;122(2 Pt 1):210-217.
15.Schmeler KM, Mayo-Smith WW, Peipert JF, Weitzen S, Manuel MD, Gordinier ME. Adnexal masses in pregnancy: surgery compared with observation. Obstet Gynecol. 2005 May;105(5 Pt 1):1098-103.
16.McDonald JM, Modesitt SC. The incidental postmenopausal adnexal mass. Clin Obstet Gynecol. 2006 Sep;49(3):506-16.
17.Kwak DW, Sohn YS, Kim SK, Kim IK, Park YW, Kim YH. Clinical experiences of fetal ovarian cyst: diagnosis and consequence. J Korean Med Sci. 2006 Aug;21(4):690-4.
18.Jain KA. Sonographic spectrum of hemorrhagic ovarian cysts. J Ultrasound Med. 2002 Aug;21(8):879-86.
19.Manique MES, Ferreira AMAP. Polycystic Ovary Syndrome in Adolescence: Challenges in Diagnosis and Management. Rev Bras Ginecol Obstet. 2022 Apr;44(4):425-433.
20.Killackey MA, Neuwirth RS. Evaluation and management of the pelvic mass: a review of 540 cases. Obstet Gynecol. 1988 Mar;71(3 Pt 1):319-22.
21.Pradhan P, Thapa M. Dermoid Cyst and its bizarre presentation. JNMA J Nepal Med Assoc. 2014 Apr-Jun;52(194):837-44.
22.Khati NJ, Kim T, Riess J. Imaging of Benign Adnexal Disease. Radiol Clin North Am. 2020 Mar;58(2):257-273.
23.Nezhat F, Apostol R, Mahmoud M, el Daouk M. Malignant transformation of endometriosis and its clinical significance. Fertil Steril. 2014 Aug;102(2):342-4.
24.Nezhat FR, Apostol R, Nezhat C, Pejovic T. New insights in the pathophysiology of ovarian cancer and implications for screening and prevention. Am J Obstet Gynecol. 2015 Sep;213(3):262-7.
25.Bailey CL, Ueland FR, Land GL, DePriest PD, Gallion HH, Kryscio RJ, van Nagell JR. The malignant potential of small cystic ovarian tumors in women over 50 years of age. Gynecol Oncol. 1998 Apr;69(1):3-7.
26.Bridwell RE, Koyfman A, Long B. High risk and low prevalence diseases: Ovarian torsion. Am J Emerg Med. 2022 Jun;56:145-150.
27.Le T, Giede C. No. 230-Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian Masses. J Obstet Gynaecol Can. 2018 Mar;40(3):e223-e229.
28.Wilkinson C, Sanderson A. Adnexal torsion — a multimodality imaging review. Clin Radiol. 2012 May;67(5):476-83.
29.Grunau GL, Harris A, Buckley J, Todd NJ. Diagnosis of Ovarian Torsion: Is It Time to Forget About Doppler? J Obstet Gynaecol Can. 2018 Jul;40(7):871-875.
30.Grimes DA, Jones LB, Lopez LM, Schulz KF. Oral contraceptives for functional ovarian cysts. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006134.
31.Glanc P, Salem S, Farine D. Adnexal masses in the pregnant patient: a diagnostic and management challenge. Ultrasound Q. 2008 Dec;24(4):225-40.
32.Giuntoli RL, Vang RS, Bristow RE. Evaluation and management of adnexal masses during pregnancy. Clin Obstet Gynecol. 2006 Sep;49(3):492-505.
33.Modesitt SC, Pavlik EJ, Ueland FR, DePriest PD, Kryscio RJ, van Nagell JR. Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter. Obstet Gynecol. 2003 Sep;102(3):594-9.